IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.
about
Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overviewImmune cell interplay in colorectal cancer prognosisIL-17 family: cytokines, receptors and signalingRole of TH17 cytokines in the control of colorectal cancerTh17 Cell Plasticity and Functions in Cancer ImmunityU87MG glioma cells overexpressing IL-17 acclerate early-stage growth in vivo and cause a higher level of CD31 mRNA expression in tumor tissuesChronic inflammation and cytokines in the tumor microenvironment.Bacterial oncogenesis in the colonImpact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal CancerInterleukin-17 Indirectly Promotes M2 Macrophage Differentiation through Stimulation of COX-2/PGE2 Pathway in the Cancer Cells.Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.Prognostic significance of interleukin 17 in cancer: a meta-analysis.An Inflammatory Cytokine Milieu is Prominent in Premalignant Oral Lesions, but Subsides when Lesions Progress to Squamous Cell Carcinoma.IL-22 is related to development of human colon cancer by activation of STAT3.IL-17/miR-192/IL-17Rs regulatory feedback loop facilitates multiple myeloma progressionTh17/IL-17A might play a protective role in chronic lymphocytic leukemia immunity.Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway.Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancerA novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes' stages A-D colorectal cancers.Involvement of IL17A, IL17F and IL23R Polymorphisms in Colorectal Cancer TherapyPrognostic significance of interleukin-17 in solid tumors: a meta-analysis.A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer.A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimenLow stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer.Complex role of γδ T-cell-derived cytokines and growth factors in cancer.Trial watch: Prognostic and predictive value of the immune infiltrate in cancerThe role of IL-17 in vitiligo: A reviewEnrichment of Inflammatory IL-17 and TNF-α Secreting CD4(+) T Cells within Colorectal Tumors despite the Presence of Elevated CD39(+) T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasisInnate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse modelAcute blockade of IL-25 in a colitis associated colon cancer model leads to increased tumor burden.Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina.Reduction of Murine Colon Tumorigenesis Driven by Enterotoxigenic Bacteroides fragilis Using Cefoxitin TreatmentInterleukin-17 and type 17 helper T cells in cancer management and research.IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma.Interleukin-17: a promoter in colorectal cancer progression
P2860
Q26774619-7DCF58F2-0890-42C2-BBAF-EFC7BA7A410FQ26781453-26939F11-BC7C-4DE5-ADBE-CDE0AEA97724Q26860251-CB183A74-2029-4227-A279-1A7DF9D99874Q26860784-C91017D8-4DAF-4339-B803-25CB2F77664AQ27012901-9C76D8FC-9A38-48EA-BF3E-F351EE8A04D5Q28674494-C3B08F87-D4F6-4380-9048-3F13BE278633Q33678275-3C1D4221-5C5D-4826-89E2-4058B331D05AQ33737879-7A1C2A56-0037-4210-B248-DCE7547FD90AQ33776744-80935658-6D3B-4444-A6FD-E2BAEF02D4A5Q34043416-E1D2C9FD-5A1E-4F21-92A1-54CDF623249EQ34218825-9E34B0B5-85C3-40B4-BA53-EDD0CE24DDDDQ34294055-8CF80A5C-0240-4932-A943-2C3B497AFC39Q34547722-C2F495D6-5C8B-4A4C-9A1F-7025B88E4429Q34556117-59871FD5-659A-411D-8C42-8FB2B5E886D0Q34573878-401D6AA5-7E2E-4C44-AA03-387865BB7E64Q34663126-4074A81F-AFA7-4745-A51D-11BF16656FDBQ35040785-6395DDFF-3140-4BDE-88F7-480CF38DE29BQ35175783-C41FB9FF-2C2B-4A00-B472-0EBDCBB90DD5Q35201856-DA56FC2C-DEEF-42E2-AC55-4DEF9E88CA95Q35619009-4728883F-A1CE-40C6-856B-77FADA99C50AQ35665693-CF9626AC-84FB-42AF-BF54-F82B9A2FE064Q36046142-D7B1BEF0-5821-411C-928B-454BE6EF7A1AQ36080701-A1523287-992F-422D-AC2B-DE5B56EE12E7Q36242082-8A7250B4-9EE7-46BB-A1A8-C5046AE678BAQ36324344-E6A4BC54-B2E3-484C-B373-C1BFFA34538CQ36432125-FDCAD34A-27FE-4DE6-A8EA-61664AA93B1DQ36444174-0112F22E-5DF2-4304-8124-EF0831F64295Q36456483-A061F2C1-2A3F-40FE-A2AE-74BFD236F22DQ36625953-489FAD3B-6020-444F-9B06-80E58BC1A8BEQ36658129-38CC33CC-693F-4927-B9ED-27015A2F12DCQ36695084-EC46F08F-0EF7-4576-A658-59D2BA8AAD54Q36754425-2864E17C-D95A-4D1A-99AC-3389A75E8F89Q36822687-8ABCDA72-A593-4C1B-86D7-C985F3FB978AQ36890647-44824D5C-7BA0-4FC7-A87F-524ACFB8C17EQ36917913-CC7D86E3-E547-4678-8FFC-F22FD6E5B30AQ37000362-D7B4C11D-AF70-4A44-82CC-0ABFFF960660Q37003024-D4F2D8B3-849D-461A-B116-86C039528573Q37031654-14C064BA-44E2-4D3B-8F85-442EA58C0ADBQ37397237-8961E98D-57A1-4345-8D59-BC87732B3501Q37409208-06372A83-AB82-4FD5-948C-A7106EF1AD1E
P2860
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@ast
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@en
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@nl
type
label
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@ast
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@en
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@nl
prefLabel
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@ast
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@en
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@nl
P2093
P1476
IL-17 is associated with poor ...... cells in colorectal carcinoma.
@en
P2093
Haixia Long
Jiankun Liu
Xiaoming Cheng
Yuzhong Duan
Zhihua Lin
P304
P356
10.1016/J.BBRC.2011.03.021
P407
P577
2011-03-09T00:00:00Z